Misty D. Bear

Characterization of STAT3 activation and expression in canine and human osteosarcoma

Stacey Fossey, Albert Taiching Liao, Jennifer McCleese et al. · BMC Cancer · 2009 · 114 citations · Full text

The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors

Tzu‐yin Lin, Misty D. Bear, Zhenjian Du et al. · Experimental Hematology · 2008 · 109 citations

Tumor Biology, Malignant Disease, Medicine +7

Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines

Stacey Fossey, Misty D. Bear, William C. Kisseberth et al. · BMC Cancer · 2011 · 109 citations · Full text

Preclinical Evaluation of the Novel, Orally Bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in Spontaneous Canine Cancer: Results of a Phase I Study

Cheryl A. London, Luis Feo Bernabé, Sandra Barnard et al. · PLoS ONE · 2014 · 101 citations · Full text

The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines

Stacey Fossey, Misty D. Bear, Jiayuh Lin et al. · BMC Cancer · 2011 · 92 citations · Full text